Commonwealth Bank of Australia’s DexCom DXCM Stock Holding History

Commonwealth Bank of Australia’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-548	Closed	-$19K	–	297
2019 Q2	$19K	Buy	+548	New	+$17.2K	﹤0.01%	1047
2017 Q3	–	Sell	-1,200	Closed	-$21K	–	860
2017 Q2	$21K	Buy	1,200 +800	+200%	+$14.8K	﹤0.01%	850
2017 Q1	$8K	Buy	+400	New	+$7.81K	﹤0.01%	877

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Commonwealth Bank of Australia's DXCM Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of DexCom (DXCM) in Q3 2019, closing a stake of 548 shares — an estimated $19K sold.

Commonwealth Bank of Australia first reported a position in DXCM in Q1 2017 and held it in 3 quarters. The position peaked at $21K in Q2 2017. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

Commonwealth Bank of Australia reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 548 DexCom shares in Q3 2019, an estimated $19K.
Commonwealth Bank of Australia first reported a position in DexCom in Q1 2017 and held it in 3 quarters.
Commonwealth Bank of Australia's DexCom position peaked at $21K in Q2 2017.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.